Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
255 SEK | -0.78% | -2.67% | +20.28% |
May. 03 | CellaVision AB Approves the Dividend, Payable on 13 May 2024 | CI |
Apr. 25 | Transcript : CellaVision AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Sales 2024 * | 782M 74.27M | Sales 2025 * | 889M 84.35M | Capitalization | 6.08B 577M |
---|---|---|---|---|---|
Net income 2024 * | 172M 16.33M | Net income 2025 * | 217M 20.6M | EV / Sales 2024 * | 7.6 x |
Net cash position 2024 * | 138M 13.07M | Net cash position 2025 * | 212M 20.15M | EV / Sales 2025 * | 6.61 x |
P/E ratio 2024 * |
35.5
x | P/E ratio 2025 * |
28
x | Employees | - |
Yield 2024 * |
0.97% | Yield 2025 * |
1.18% | Free-Float | 82.65% |
Latest transcript on CellaVision AB
1 day | -0.78% | ||
1 week | -2.67% | ||
Current month | -2.67% | ||
1 month | +12.33% | ||
3 months | +13.59% | ||
6 months | +48.95% | ||
Current year | +20.28% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Simon Ostergaard
CEO | Chief Executive Officer | 53 | 21-03-20 |
Magnus Blixt
DFI | Director of Finance/CFO | 58 | 13-05-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Lotta Jarleryd
BRD | Director/Board Member | 58 | 22-05-10 |
Mikael Worning
CHM | Chairman | 62 | 20-04-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 255 | -0.78% | 14,125 |
24-06-05 | 257 | -2.10% | 5,542 |
24-06-04 | 262.5 | -2.78% | 13,358 |
24-06-03 | 270 | +3.05% | 15,396 |
24-05-31 | 262 | -6.26% | 64,950 |
Delayed Quote Nasdaq Stockholm, June 07, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.28% | 577M | |
-26.77% | 16.48B | |
-43.46% | 2.79B | |
+22.46% | 1.94B | |
-12.32% | 1.46B | |
+31.49% | 1.33B | |
-16.15% | 966M | |
+1.33% | 791M | |
-31.07% | 788M | |
-25.95% | 620M |
- Stock Market
- Equities
- CEVI Stock